| 股骨颈骨折合并2型糖尿病患者应用胰岛素泵与胰岛素类似物多次注射疗效及医疗费用的比较 |
| 投稿时间：2017-02-24 修订日期：2017-03-06 点此下载全文 |
| 引用本文：李伟,左庆瑶,陈佳,王志新,霍丽丽,王红,邓微.股骨颈骨折合并2型糖尿病患者应用胰岛素泵与胰岛素类似物多次注射疗效及医疗费用的比较[J].医学研究杂志,2017,46(12):32-36 |
| DOI：
10.11969/j.issn.1673-548X.2017.12.009 |
| 摘要点击次数: 1006 |
| 全文下载次数: 806 |
|
| 基金项目:北京市医院管理局"青苗"计划项目（QML20160404） |
|
| 中文摘要:目的 通过对单侧股骨颈骨折合并新发2型糖尿病患者的短期强化降糖治疗，比较持续皮下胰岛素泵输注（CSⅡ）与长效+速效胰岛素类似多次皮下注射（MSⅡ）两种治疗方式的疗效及医疗费用。方法 随机将64例单侧股骨颈骨折合并新发2型糖尿病患者分为两组，分别给予CSⅡ治疗（33例）和MSⅡ治疗（31例）对血糖达标时间、胰岛素使用剂量、手术并发症、住院费用、住院时间等指标进行比较。结果 CSⅡ组的空腹血糖达标时间（TTF）、餐后血糖达标时间（TTP）、空腹及餐后同时达标时间（TTB）都较MSⅡ短（46.18±25.0h vs 88.9±41.0h、64.1±25.6h vs 103.9±46.9h、66.2±24.7h vs 115.5±72.1h，P<0.05）；CSⅡ组的达标时胰岛素总量、基础胰岛素用量、餐时胰岛素用量也均较MDⅡ组少（0.65±0.11IU/kg vs 0.80±0.19IU/kg、0.32±0.07IU/kg vs 0.37±0.12IU/kg、0.33±0.06IU/kg vs 0.44±0.10IU/kg，P<0.05）。平均每日基础胰岛素增减剂量CSⅡ组较MSⅡ组大[0.08±0.07IU/（kg·d） vs 0.05±0.04IU/（kg·d），P<0.05]，平均每日餐时胰岛素增减剂量CSⅡ组较MSⅡ组小[0.01±0.03U/（kg·d） vs 0.03±0.03U/（kg·d），P<0.05]。两组间住院总费用、手术费用及非手术费用两者均无差别，而CSⅡ组较MSⅡ组住院时间短、术后低蛋白血症减少（13.6±2.7天vs 15.7±3.4天，1例vs 6例，P<0.05）。MSⅡ组TTB影响因素是达标基础量、基础步长（β值为0.875、-0.677，P<0.05），非手术费用的影响因素是住院时间、下肢深静脉血栓、术后低蛋白血症（β值为0.445、0.392、0.389，P<0.05），住院天数的影响因素是术后低蛋白血症、TTB （β值为0.400、0.288，t值为3.596、2.101，P<0.05）；CSⅡ组TTB影响因素是达标餐时量、餐时步长（β值为0.763、-0.896，P<0.05），非手术费用的影响因素是住院时间、下肢深静脉血栓（β值为0.453、0.372，P<0.05），住院天数的影响因素是TTB （β=0.450，P<0.05）。结论 在单侧股骨颈骨折合并新发2型糖尿病患者的术前血糖控制方面，持续皮下胰岛素泵输注疗法优于长效+速效胰岛素类似多次皮下注射疗法。住院费用两者相同，但持续皮下胰岛素泵输注疗法可能通过减少住院时间进一步节省社会资源。 |
| 中文关键词:糖尿病 骨折围术期 胰岛素泵 胰岛素类似物 住院费用 |
| |
| Comparison of Efficacy and Medical Cost of Continuous Subcutaneous Insulin Injection versus Multiple Injection of Insulin Analogue in Patients with Femoral Neck Fracture Complicated with Type 2 Diabetes Mellitus. |
|
|
| Abstract:Objective To clarify the efficacy and medical costs of two different perioperative insulin treatment protocol, continuous subcutaneous insulin injection (CSⅡ) and multiple subcutaneous insulin injections (MSⅡ) in patients with unilateral femoral neck fracture complicated with newly-diagnosed type 2 diabetes mellitus (T2DM).Methods A total of 64 subjects were enrolled in this study and they were randomly divided into two groups, CSⅡ and MSⅡ. CSⅡ group (n=33) were treated with rapid-acting insulin analog while MSⅡ group (n=31) were treated with long-acting and rapid-acting analog. The time of reaching glucose target for perioperative requirements, the dosages of insulin, the incidence of perioperative complications, the length of hospital stay and the medical cost of the two groups were analyzed.Results Compared with MSⅡ group, CSⅡ group had shorter time to achieve the therapeutic target of fasting glucose (TTF), of postprandial glucose (TTP) and of the both (TTB) (CSⅡ vs MSⅡ, 46.18±25.0h vs 88.9±41.0h; 64.1±25.6h vs 103.9±46.9h; 66.2±24.7h vs 115.5±72.1h, P<0.05). The dosages of total, basal and mealtime insulin of CSⅡ group were smaller than that of MSⅡ group when glycemic target achieved (0.65±0.11IU/kg vs 0.80±0.19IU/kg; 0.32±0.07IU/kg vs 0.37±0.12IU/kg; 0.33±0.06IU/kg vs 0.44±0.10IU/kg, P<0.05). The average change of daily basal insulin dosage of CSⅡ was greater than that of MSⅡ[0.08±0.07IU/(kg·d) vs 0.05±0.04IU/(kg·d), P<0.05], while the average change of daily mealtime insulin dosage of CSⅡ was smaller than that of MSⅡ[0.01±0.03IU/(kg·d) vs 0.03±0.03IU/(kg·d), P<0.05]. Although there were no significant difference in the total medical cost, in the operation cost and in the non-operative cost between the two groups, the CSⅡ group had shorter hospital stay and lower incidence of postoperative hypoalbuminemia (13.6±2.7 vs 15.7±3.4, P<0.05).Conclusion With regard to the management of perioperative hyperglycemia in patients with unilateral femoral neck fracture, CSⅡ was superior to MSⅡ. Although the medical cost of the two protocols were similar, protocol of CSⅡ might further save social resources by reducing the length of hospital stay. |
| keywords:Diabetes mellitus Fracture perioperative period Continuous subcutaneous insulin injection Insulin analogue Medical cost |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|
